Director - Investor Relations

ARCHIMED•New York, NY

20h

About The Position

Reporting to the Head of Investor Relations, the Director of Investor Relations will play a leadership role in the strategic direction and execution of ARCHIMED's global capital formation and LP engagement efforts. This is a senior, high-visibility position with direct exposure to the firm's Partners and leadership, significant LP-facing responsibility and ownership of material components of the IR function.

Requirements

Senior IR professional with approximately 10 to 15 years of relevant experience in investor relations, fundraising or LP coverage within private equity or alternative asset management.
Prior experience raising institutional capital at scale is essential.
Established network of institutional LP relationships across multiple geographies, with a demonstrated ability to manage complex relationships independently and convert dialogue into commitments.
Strong financial acumen.
Fluency with fund structuring, LPA terms, performance metrics (gross and net IRR, TVPI, DPI, PME), portfolio analytics and the quantitative diligence expected by sophisticated LPs.
Deep knowledge of market practice, fund terms, fee structures and the competitive landscape in healthcare and broader PE.
Exceptional communicator. Able to translate complex investment theses, industry dynamics and deal structures into clear, factual narratives for the most sophisticated audiences.
Commercial mindset and entrepreneurial orientation. Capable of identifying new market opportunities, new channels and new product formats to expand AUM.
Proven ability to operate in a fast-paced environment, manage competing priorities and deliver under pressure without sacrificing quality.
Advanced Excel and PowerPoint skills.
Fluency with IR CRM systems (Dynamo, Backstop, Altvia or similar) preferred.
Higher education degree in finance, economics or business administration.
CFA or MBA a plus.
Embodies ARCHIMED's cultural values of inclusion, meritocracy, partnership, accountability, client focus and trust.

Responsibilities

Partner with the Head of Investor Relations and firm leadership to shape fundraising strategy across flagship funds, co-investment vehicles and GP-led secondaries, including market positioning, investor segmentation and campaign sequencing.
Own the end-to-end production of institutional-quality fundraising materials (PPM, DDQ, pitch decks, VDR, track record analytics) and manage the legal and structural workstreams alongside external counsel and service providers.
Serve as a senior external voice for the firm.
Represent ARCHIMED at investor conferences, industry events and LP meetings, and articulate the firm's strategy, performance and impact thesis with credibility and precision.
Build, deepen and independently manage a portfolio of global LP relationships across sovereign wealth funds, pension plans, insurance companies, endowments, foundations, fund of funds, family offices and consultants.
Identify and cultivate new pools of capital to support the firm's growth trajectory.
Lead select roadshows, drive pipeline development and hold direct accountability for LP commitments and conversion metrics.
Oversee the operation of the firm's IR program, including quarterly and annual fund and co-investment reporting in partnership with Finance, Impact and Investment Teams.
Own LP servicing including capital calls, distributions, information requests, secondary transfers and bespoke LP workstreams, and establish the standards and playbooks that scale with AUM growth.
Lead the planning and delivery of the Investor AGM and other flagship LP events in close coordination with the Communications team.
Mentor and develop junior IR team members and contribute to the build-out of the function as the platform grows.
Drive the firm's co-investment program with existing LPs and the broader institutional community, working alongside deal teams to syndicate opportunities efficiently and on favorable terms.
Contribute to the strategic evolution of ARCHIMED's fund platform by structuring and leading GP-led secondaries, continuation vehicles and other bespoke capital solutions where appropriate.